Carbon ion radiotherapy in Japan: An assessment of 20 years of clinical experience

The Lancet Oncology

Volumn 16, Issue 2, 2015, Pages e93-e100

  Kamada, Tadashi ^a   Tsujii, Hirohiko ^a   Blakely, Eleanor A ^b   Debus, Jürgen ^c   De Neve, Wilfried ^d   Durante, Marco ^e   Jäkel, Oliver ^c   Mayer, Ramona ^f   Orecchia, Roberto ^g,h   Pötter, Richard ⁱ   Vatnitsky, Stanislav ^f   Chu, William T ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d GHENT UNIVERSITY   (Belgium)

^e DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^f MedAustron GmbH   (Austria)

^g Centro Nazionale Adroterapia Oncologica CNAO   (Italy)

^h EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE TUMOR; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); COST BENEFIT ANALYSIS; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; INTERNATIONAL COOPERATION; ION THERAPY; JAPAN; LIVER CELL CARCINOMA; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PANCREAS CANCER; PEER REVIEW; PROSTATE CANCER; PROTON THERAPY; RADIOBIOLOGY; RECTUM CANCER; SOFT TISSUE TUMOR; STEREOTACTIC BODY RADIATION THERAPY; UTERINE CERVIX CANCER; NEOPLASMS; TIME;

CARBON;

CARBON; HEAVY ION RADIOTHERAPY; HUMANS; JAPAN; NEOPLASMS; TIME FACTORS;

EID: 84921731797     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70412-7     Document Type: Review

References (51)

1. Halperin EC Particle therapy and treatment of cancer. Lancet Oncol 2006, 7:676-685.
2. Bekelman JE, Hahn SM The body of evidence for advanced technology in radiation oncology. J Natl Cancer Inst 2013, 105:6-7.
3. Jermann M Particle therapy statistics in 2013. Int J Particle Ther 2014, 1:40-43.
4. Schulz-Ertner D, Tsujii H Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007, 25:953-964.
5. Amaldi U, Kraft G Radiotherapy with beams of carbon ions. Rep Prog Phys 2005, 68:1861-1882.
6. Loeffler JS, Durante M Charged particle therapy--optimization, challenges and future directions. Nat Rev Clin Oncol 2013, 10:411-424.
7. Durante M, Reppingen N, Held KD Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med 2013, 19:565-582.
8. Durante M, Loeffler JS Charged particles in radiation oncology. Nat Rev Clin Oncol 2010, 7:37-43.
9. Terasawa T, Dvorak T, Ip S, Raman G, Lau J, Trikalinos TA Systematic review: charged-particle radiation therapy for cancer. Ann Intern Med 2009, 151:556-565.
10. De Ruysscher D, Mark Lodge M, Jones B, et al. Charged particles in radiotherapy: a 5-year update of a systematic review. Radiother Oncol 2012, 103:5-7.
11. Allen AM, Pawlicki T, Dong L, et al. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol 2012, 103:8-11.
12. Combs SE, Debus J Treatment with heavy charged particles: systematic review of clinical data and current clinical (comparative) trials. Acta Oncol 2013, 52:1272-1286.
13. Castro JR, Saunders WM, Tobias CA, et al. Treatment of cancer with heavy charged particles. Int J Radiat Oncol Biol Phys 1982, 8:2191-2198.
14. Deye JA NCI support for particle therapy: past, present, future. Health Phys 2012, 103:662-666.
15. Workshop on Ion Beam Therapy - Summary Report. Jan 9-10, 2013 DOE-NCI, (accessed Sept 22, 2014). http://science.energy.gov/~/media/hep/pdf/accelerator-rd-stewardship/Workshop_on_Ion_Beam_Therapy_Report_Final_R1.pdf.
16. Furukawa T, Inaniwa T, Hara Y, Mizushima K, Shirai T, Noda K Patient-specific QA and delivery verification of scanned ion beam at NIRS-HIMAC. Med Phys 2013, 40:121707.
17. Okada T, Kamada T, Tsuji H, et al. Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (Tokyo) 2010, 51:355-364.
18. Kamada T Clinical evidence of particle beam therapy (carbon). Int J Clin Oncol 2012, 17:85-88.
19. Tsujii H, Kamada T A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol 2012, 42:670-685.
20. Carbon-ion radiotherapy 2014, Springer-Verlag, Berlin. H. Tsujii, T. Kamada, T. Shirai (Eds.).
21. Rieken S, Habermehl D, Haberer T, Jaekel O, Debus J, Combs SE Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts. Radiat Oncol 2012, 7:41.
22. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004, 58:631-640.
23. Senan S, Paul MA, Lagerwaard FJ Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?. Lancet Oncol 2013, 14:e270-e274.
24. Imai R, Kamada T, Sugahara S, Tsuji H, Tsujii H Carbon ion radiotherapy for sacral chordoma. Br J Radiol 2011, 84:S48-S54.
25. Carozzo S, Schardt D, Narici L, Combs SE, Debus J, Sannita WG Electrophysiological monitoring in patients with tumors of the skull base treated by carbon-12 radiation therapy. Int J Radiat Oncol Biol Phys 2013, 85:978-983.
26. Proton therapy for prostate cancer: time for evidence. Lancet Oncol 2014, 15:775. The Lancet Oncology.
27. Sheets NC, Goldin GH, Meyer AM, et al. Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 2012, 307:1611-1620.
28. Yu JB, Soulos PR, Herrin J, et al. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst 2013, 105:25-32.
29. Pugh TJ, Munsell MF, Choi S, et al. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2013, 87:946-953.
30. Chiba T, Tokuuye K, Matsuzaki Y, et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 2005, 11:3799-3805.
31. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 2006, 64:1129-1139. the Study Group for Therapies of Rectal Malignancies (STORM).
32. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E European cancer mortality predictions for the year 2014. Ann Oncol 2014, 25:1650-1656.
33. Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin 2013, 63:318-348.
34. Pötter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011, 100:116-123.
35. Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer. J Natl Compr Canc Netw 2013, 11:320-343. the National Comprehensive Cancer Network.
36. Peeters A, Grutters JP, Pijls-Johannesma M, et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons. Radiother Oncol 2010, 95:45-53.
37. Yonai S, Matsufuji N, Namba M Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation. Med Phys 2012, 39:5028-5039.
38. Newhauser WD, Durante M Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer 2011, 11:438-448.
39. Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys 2013, 87:46-52.
40. Mizoe JE, Tsujii H, Hasegawa A, et al. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2007, 69:390-396. the Organizing Committee of the Central Nervous System Tumor Working Group.
41. Combs SE, Bruckner T, Mizoe JE, et al. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis. Radiother Oncol 2013, 108:132-135.
42. Combs SE, Burkholder I, Edler L, et al. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial. BMC Cancer 2010, 10:533.
43. Relative biological effectiveness in ion beam therapy 2008, IAEA, International Atomic Energy Agency, Technical Report Series no 461, Vienna.
44. Inaniwa T, Furukawa T, Kase Y, et al. Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model. Phys Med Biol 2010, 55:6721-6737.
45. Friedrich T, Scholz U, Durante M, Scholz M RBE of ion beams in hypofractionated radiotherapy (SBRT). Phys Med 2014, 30:588-591.
46. Fossati P, Molinelli S, Matsufuji N, et al. Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy. Phys Med Biol 2012, 57:7543-7554.
47. Steinsträter O, Grün R, Scholz U, Friedrich T, Durante M, Scholz M Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy. Int J Radiat Oncol Biol Phys 2012, 84:854-860.
48. Formenti SC, Demaria S Systemic effects of local radiotherapy. Lancet Oncol 2009, 10:718-726.
49. Iwata Y, Noda K, Murakami T, et al. Development of a superconducting rotating-gantry for heavy-ion therapy. Nucl Instrum Methods Phys Res B 2013, 317B:793-797.
50. Jensen AD, Münter MW, Debus J Review of clinical experience with ion beam radiotherapy. Br J Radiol 2011, 84:S35-S47.
51. Tuan J, Vischioni B, Fossati P, et al. Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO). J Radiat Res (Tokyo) 2013, 54(suppl 1):i31-i42.